The main finding of this study is that APC mutations, as could be detected by coverage of the TSACP analysis, were associated with a poor DFS in stage III MSS colon cancer patients (p = 0.005; HR = 4.1; Figure 4B). Here, APC is linked to malignant colon neoplasm.